| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 586.70M | 561.30M | 586.50M | 622.20M | 594.30M | 398.60M |
| Gross Profit | 258.50M | 249.70M | 245.80M | 247.60M | 239.00M | 156.10M |
| EBITDA | 115.10M | 107.20M | 102.00M | 92.00M | 104.20M | 57.90M |
| Net Income | 49.00M | 33.50M | 38.50M | 36.50M | 41.00M | 18.50M |
Balance Sheet | ||||||
| Total Assets | 992.80M | 993.00M | 978.80M | 1.03B | 1.03B | 699.80M |
| Cash, Cash Equivalents and Short-Term Investments | 34.90M | 43.60M | 17.00M | 50.00M | 52.30M | 44.10M |
| Total Debt | 174.70M | 172.80M | 166.30M | 216.20M | 218.00M | 71.80M |
| Total Liabilities | 344.20M | 350.00M | 342.20M | 401.10M | 408.30M | 198.90M |
| Stockholders Equity | 648.60M | 643.00M | 636.60M | 627.10M | 617.70M | 500.90M |
Cash Flow | ||||||
| Free Cash Flow | 63.40M | 79.50M | 63.10M | 43.10M | 40.30M | 28.20M |
| Operating Cash Flow | 88.50M | 105.10M | 97.60M | 86.90M | 74.90M | 53.30M |
| Investing Cash Flow | -29.40M | -27.90M | -28.50M | -44.00M | -270.50M | -26.30M |
| Financing Cash Flow | -40.50M | -50.60M | -102.10M | -45.20M | 203.90M | -30.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £1.29B | 31.32 | 16.10% | 1.68% | 20.57% | -3.18% | |
74 Outperform | £291.43M | 23.03 | 10.01% | 3.48% | -3.93% | 41.83% | |
71 Outperform | £817.84M | 16.66 | 7.68% | 3.19% | 5.88% | 107.36% | |
70 Neutral | £126.72M | 17.16 | 7.23% | 3.97% | 5.51% | -33.75% | |
70 Neutral | £581.69M | 14.22 | 22.36% | 5.91% | -4.70% | -2.21% | |
65 Neutral | £173.20M | 34.34 | 9.50% | 4.39% | -3.51% | -67.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
Genuit Group plc has confirmed that as of 31 December 2025 it had 250,884,071 ordinary shares of £0.001 each in issue, of which 375 are held in treasury, resulting in 250,883,696 voting rights attached to its issued share capital. The updated share and voting rights figure provides investors with the official denominator for calculating and disclosing their holdings or changes in holdings under FCA transparency rules, helping maintain accurate market reporting and regulatory compliance.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £362.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group plc announced a transaction involving its Chief Executive Officer, Joe Vorih, who acquired 8,144 ordinary shares following the exercise of options granted under the company’s 2014 Sharesave Plan. This transaction, valued at £17,998.24, reflects the CEO’s increased stake in the company, potentially signaling confidence in Genuit Group’s future performance and strategic direction.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £362.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group plc announced that CEO Joe Vorih exercised options to acquire a total of 14,059 ordinary shares under the company’s Long-Term Incentive Plan and Deferred Share Bonus Plan. Following the exercise, Vorih sold a portion of the shares to cover tax liabilities and now holds 143,611 shares. This transaction aligns with regulatory requirements and reflects the company’s ongoing commitment to incentivizing leadership through equity participation, potentially impacting stakeholder confidence and market perception.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £362.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group plc has announced the acquisition of ordinary shares by key managerial personnel, including Martin Gisbourne, Emma Versluys, and Steve Currier, as part of the vesting of a conditional share award under the company’s 2014 Long-Term Incentive Plan. This transaction, conducted outside a trading venue, reflects the company’s commitment to aligning its leadership’s interests with long-term strategic goals, potentially strengthening its market position and enhancing stakeholder confidence.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £394.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group plc announced a transaction involving Martin Gisbourne, the Chief Strategy and Sustainability Officer, who acquired 8,144 ordinary shares following the exercise of options granted under the company’s 2014 Sharesave Plan. This transaction, valued at £17,998.24, reflects the company’s ongoing commitment to aligning management interests with shareholder value and could potentially impact its market positioning by demonstrating confidence in its strategic direction.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £394.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group plc has applied to the London Stock Exchange and FCA for the admission of 2,500,000 ordinary shares to satisfy awards under its various incentive and share plans. This move is part of the company’s strategy to manage employee compensation and align interests with shareholders, with the shares expected to start trading on 21 November 2025.
The most recent analyst rating on (GB:GEN) stock is a Hold with a £326.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group plc has announced the purchase of ordinary shares by several key executives, including the Chair, CEO, CFO, and other directors, as part of their investment in the company. These transactions, conducted on the London Stock Exchange, reflect a significant vote of confidence in the company’s future prospects and strategic direction, potentially impacting stakeholder perceptions positively.
The most recent analyst rating on (GB:GEN) stock is a Hold with a £326.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group plc reports resilient trading and market share gains despite a subdued market, with revenue growth of 7.1% for the four months ended October 2025. The company expects full-year underlying operating profit to be between £92 million and £95 million, reflecting market volume moderation due to economic uncertainties. Strategic progress includes acquisitions of Monodraught and Davidson Holdings, expected to generate significant revenue in 2026. Genuit continues to focus on productivity improvements and operational efficiencies to counteract market challenges, positioning itself well for future market recovery.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £404.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.
Genuit Group plc has announced the grant of three-year options under its 2024 Sharesave Plan to key personnel, including Edel Conway, Chief People Officer, and Steve Currier, interim Managing Director of Water Management Solutions and Sustainable Building Solutions. This move is part of the company’s strategy to align managerial interests with shareholder value and enhance employee engagement, potentially impacting its operational efficiency and market positioning.
The most recent analyst rating on (GB:GEN) stock is a Buy with a £520.00 price target. To see the full list of analyst forecasts on Genuit Group stock, see the GB:GEN Stock Forecast page.